A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
Year: 2022
Type: article
Authors: Karthik Nath, Tala Shekarkhand, Meghan Salcedo, Andriy Derkach, Siobhan Rueda, Aisara Chansakul, Malin Hulcrantz, Neha Korde, Urvi A. Shah, Carlyn Tan, David J. Chung, Oscar B. Lahoud, Hani Hassoun, Alexander M. Lesokhin, Heather J. Landau, Gunjan Shah, Michael Scordo, Sergio A. Giralt, Saad Z. Usmani, Mikhail Roshal, Ola Landgren, Sham Mailankody
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Janssen Pharmaceuticals
OpenAlex ID: W4307234262